Latest Operational Efficiency News

Chemist Warehouse Group has delivered a standout first half in FY25, reporting record sales growth and a significant expansion in EBIT margins, driven by new store openings and international expansion.

Burgundy Diamond Mines reported a dip in Q4-2024 production and revenue amid operational transitions but maintains a bullish outlook for 2025 driven by strategic mine development and market recovery.

Bathurst Resources reported a first half EBITDA of $27.5 million, surpassing forecasts despite export disruptions, yet lowered its full-year EBITDA guidance to $45-$55 million due to reduced export volumes and softer coal prices.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Hydrix Limited reports back-to-back profitable quarters driven by strong margins and cost efficiencies, underpinned by a robust $40 million sales opportunity pipeline in cardiac and medtech sectors.

Bowen Coking Coal reported a strong December quarter with record coal sales and a 39% reduction in cash costs, underpinning a $29 million EBITDA despite softer coal prices.

XPON Technologies reports a modest 2% increase in martech revenue and a strong cash position for Q2 FY25, while navigating an 8% decline in annualised recurring revenue amid strategic sales recalibration.

Myer Holdings has completed its strategic acquisition of Just Group, adding five key apparel brands to its portfolio and issuing 890.5 million new shares to Premier Investments.

Pureprofile Limited has upgraded its FY25 financial guidance following a robust first half, highlighted by a 22% revenue increase and a 30% surge in Q2, driven by strong international expansion and automation adoption.

Metro Mining Limited delivered record bauxite shipments in Q4 2024, alongside a successful debt restructure and strong EBITDA margins, positioning the company for growth amid rising market prices.

Stellar Resources reports outstanding ore sorting results at its Heemskirk Tin Project, achieving a 2.4-fold increase in tin head grade and up to 95% tin recovery, promising significant cost savings and enhanced production potential.

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.